Myopia Management with DIMS
Second-generation myopia-control spectacle lenses and the shift toward retinal signal design
Clinical Scorecard: Myopia Management with DIMS
At a Glance
| Category | Detail |
|---|
| Condition | Myopia |
| Key Mechanisms | Axial length management and retinal signal-profile design. |
| Target Population | Children with myopia. |
| Care Setting | Clinical myopia management. |
Key Highlights
- DIMS and MiYOSMART show meaningful efficacy in axial elongation reduction.
- Second-generation lenses focus on biologically targeted retinal signals.
- Clinical data indicate significant differences in axial elongation among lens types.
- Durability and adaptation of lenses require further investigation.
- Visual performance metrics are essential for evaluating new lens designs.
Guideline-Based Recommendations
Diagnosis
- Assess axial length as a key measure in myopia management.
Management
- Utilize second-generation myopia-control lenses for effective treatment.
Monitoring & Follow-up
- Track axial elongation and visual performance over time.
Risks
- Consider potential adaptation issues and long-term outcomes.
Patient & Prescribing Data
Children experiencing myopia progression.
Second-generation lenses may provide improved axial length control.
Clinical Best Practices
- Evaluate the biological signal strength of myopia-control lenses.
- Monitor responder distribution and visual acceptability in patients.
- Ensure comprehensive follow-up to assess long-term efficacy.
Related Resources & Content
